MOLECULAR VISION AT SCALE
Live / Allowed — Approved for publication (as of 01 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99109253
- Mark type
- Stylized text
- Filed
- 28 Mar 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable computer software using artificial intelligence (AI), computational methods, and machine learning models for analysis of biomolecular structures and for the design and characterization of biologic therapeutic products; computer hardware using artificial intelligence, computational methods, and machine learning models for analysis of biomolecular structures and for the design and characterization of biologic therapeutic products; downloadable computer software using artificial intelligence and machine learning models for analyzing proteins, nucleic acids, and other biological specimens for biomedical and agricultural applications
- Class 042 — Scientific and technological services: Scientific research in the field of microscopy; providing temporary use of online, non-downloadable software using artificial intelligence, computational methods, and machine learning models for analysis of biomolecular structures and for the design and characterization of biologic therapeutic products; scientific and technological services, namely, scientific research and analysis in the fields of artificial intelligence and machine learning analytics and research relating to biomolecular structures, disease, genomics, and agricultural technology; providing temporary use of online, non-downloadable software using artificial intelligence and machine learning models for analyzing proteins, nucleic acids, and other biological specimens for biomedical and agricultural applications; scientific and technological services, namely, scientific research and analysis in the field of biological therapy, in particular for the design and characterization of biologic therapeutic products
Owner
- Flagship Labs 109, Inc., Cambridge, MA, US
Prosecution history
- 01 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 02 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 03 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Sept 2025 — NON-FINAL ACTION E-MAILED
- 03 Sept 2025 — NON-FINAL ACTION WRITTEN
- 27 Aug 2025 — ASSIGNED TO EXAMINER
- 12 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 28 Mar 2025 — NEW APPLICATION ENTERED